The editors asked two members of the Psychopharmacologic Drugsand Pediatric Advisory Committees of the Food and Drug Administrationto comment on the committees' recent recommendations regardingthe use of antidepressant medications in children and adolescents.
Their responses follow.
On September 14, 2004, a Food and Drug Administration (FDA)joint advisory committee voted 15 to 8 to recommend that a "black-box"warning label be required for antidepressant drugs, indicatingthat they increase the risk of suicidal thinking and behavior("suicidality") in pediatric patients. Although, as an epidemiologistand general pediatrician, I do not have clinical experiencecaring for depressed . . . [Full Text of this Article]
Source Information
From the Departments of Epidemiology and Biostatistics and Pediatrics, University of California San Francisco, San Francisco.
This article has been cited by other articles:
Tsapakis*, E. M., Soldani*, F., Tondo, L., Baldessarini, R. J.
(2008). Efficacy of antidepressants in juvenile depression: meta-analysis. Br. J. Psychiatry
193: 10-17
[Abstract][Full Text]
Olfson, M., Marcus, S. C., Druss, B. G.
(2008). Effects of Food and Drug Administration Warnings on Antidepressant Use in a National Sample. Arch Gen Psychiatry
65: 94-101
[Abstract][Full Text]
Hammad, T. A
(2007). Review: Benefits of antidepressants outweigh risks of suicidal ideation and attempts in children and adolescents. Evid. Based Ment. Health
10: 108-108
[Full Text]
Li, J. S., Eisenstein, E. L., Grabowski, H. G., Reid, E. D., Mangum, B., Schulman, K. A., Goldsmith, J. V., Murphy, M. D., Califf, R. M., Benjamin, D. K. Jr
(2007). Economic Return of Clinical Trials Performed Under the Pediatric Exclusivity Program. JAMA
297: 480-488
[Abstract][Full Text]
Olfson, M., Marcus, S. C., Shaffer, D.
(2006). Antidepressant drug therapy and suicide in severely depressed children and adults: a case-control study.. Arch Gen Psychiatry
63: 865-872
[Abstract][Full Text]
Healy, D.
(2006). Did regulators fail over selective serotonin reuptake inhibitors?. BMJ
333: 92-95
[Full Text]
Hammad, T. A., Laughren, T., Racoosin, J.
(2006). Suicidality in pediatric patients treated with antidepressant drugs.. Arch Gen Psychiatry
63: 332-339
[Abstract][Full Text]
Leslie, L. K., Newman, T. B., Chesney, P. J., Perrin, J. M.
(2005). The Food and Drug Administration's Deliberations on Antidepressant Use in Pediatric Patients. Pediatrics
116: 195-204
[Abstract][Full Text]
Gould, M. S., Marrocco, F. A., Kleinman, M., Thomas, J. G., Mostkoff, K., Cote, J., Davies, M.
(2005). Evaluating Iatrogenic Risk of Youth Suicide Screening Programs: A Randomized Controlled Trial. JAMA
293: 1635-1643
[Abstract][Full Text]
Martin, A., Young, C., Leckman, J. F., Mukonoweshuro, C., Rosenheck, R., Leslie, D.
(2005). Risk of Mania With Antidepressants--Reply. Arch Pediatr Adolesc Med
159: 298-299
[Full Text]
Fochtmann, L. J., Gelenberg, A. J.
(2005). Guideline Watch: Practice Guideline for the Treatment of Patients With Major Depressive Disorder, 2nd Edition. Focus
3: 34-42
[Full Text]
Previous
